A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

Andrew Don-Wauchope

Andrew Don-Wauchope, Vice President Clinical Services, LifeLabs and Professor Pathology and Molecular Medicine, McMaster University.
Dr. Don-Wauchope is a Laboratory Physician practising as a Medical Biochemist and as a clinical Endocrinologist. Dr. Don-Wauchope trained and worked in South Africa and Europe and has been located in Canada since 2007. Initially with the Hamilton Regional Laboratory Medicine Program, a regional laboratory provider associated with the McMaster University academic Hospitals and more recently with LifeLabs, Canada’s largest community laboratory service.
He holds a university appointment as Professor in Pathology and Molecular Medicine at McMaster University with an associate appointment in Internal Medicine (Division of Endocrinology). He is on the American Association of Clinical Chemistry Core Education Committee and a corresponding member of the International Federation of Clinical Chemistry evidence based laboratory medicine committee.
He has a research interest in laboratory utilisation and clinical practice guidelines and has published more than 50 peer reviewed papers. He is involved with the Choosing Wisely Canada campaign as a chair of the medical biochemistry group and a member of the clinical chemistry interest group.

Speaking in:

    Laboratory Test Overutilization: A Community Labs Perspective

Christopher Naugler

Dr. Naugler is a Professor in the Departments of Pathology, Family Medicine and Community Health Sciences at the Cuming School of Medicine at the University of Calgary. He completed medical training at Dalhousie University followed by Family medicine training at The University of Western Ontario (CCFP 1999, FCFP 2010), and specialty training in general Pathology at Dalhousie University (FRCPC 2009). He is currently the Department Head of Pathology and Laboratory Medicine at the University of Calgary and the Medical Director for Calgary Laboratory Services, a lab performing over 30 million tests per year. Dr. Naugler has over 135 peer-reviewed publications and holds grant funding of over 9 million dollars as Principal Investigator or Co-Investigator. He was the winner of the 2013 University of Calgary Faculty of Medicine Watanabe Distinguished Achievement Award for Overall Excellence. His research includes work on laboratory test appropriateness, clinical epidemiology and pathology informatics.

Speaking in:

    Overview of Laboratory Overutilization: What is the Extent of the Problem


Chris Hayes

Dr. Hayes is a 2013-14 Canadian Harkness/IHI Fellow in Health Care Policy and Practice, where he spent a year at IHI researching strategies to improve the success and sustainability of quality improvement initiatives. Formerly, Dr. Hayes was the Medical Director of Quality and Performance at St. Michael’s Hospital in Toronto, from 2006 November 2016. From 2008 to 2015 Chris was the medical officer for the Canadian Patient Safety Institute, where he chaired the Canadian Safe Surgery Saves Lives program. He is a recognized leader in patient safety and quality improvement, working with regional, national, and international organizations, and has received multiple distinctions and awards

Speaking in:

    How to Make Change Happen: The Highly Adoptable Improvement Model

Douglas Urness

Dr. Urness is currently the Zone Clinical Department Head, Addiction and Mental Health, Central Zone, Alberta Health Services. He is a Clinical Assistant Professor in the Department of Psychiatry at the University of Calgary. He is clinically active in the areas of in-patient psychiatry, Mental Health Clinics, Transcranial Magnetic Stimulation and Telepsychiatry. He is the past Chair of the Canadian Psychiatric Association Professional Standards and Practices Committee, an ongoing member of the CPA’s working group on Choosing Wisely and has contributed extensively to the development of the
Choosing Wisely Canada Psychiatry Recommendations. He was also involved in the recently released Canadian Guidelines for Schizophrenia. Dr. Urness is a graduate of the University of Alberta Medical School and Psychiatry Residency Training Programs.

Speaking in:

    A Successful Change Strategy Addressing Overutilization of Stat Drug Tests, with Emphasis on Collaboration between Labs and Clinical Staff

Julie Gilmour

Julie is a clinician in quality and innovation and Assistant Professor in the Division of Endocrinology.
Julie completed her Endocrinology training at the University of Toronto and received a Master’s of Science in Healthcare Quality Improvement from Queen’s University. Julie has an interest is in resource stewardship, specifically related to laboratory-based testing. She was the lead clinician responsible for implementing the reflex thyroid hormone system at SMH, which is aimed at reducing unnecessary free thyroid hormone tests – one of the Choosing Wisely Canada recommendations.

Speaking in:

    Reflexive Testing: An Overutilization Change Strategy


Kent Lewandrowski

Kent Lewandrowski, M.D. is the Director of Pathology Laboratories and Molecular Medicine and Associate Chief of Pathology at the Massachusetts General Hospital. He is also director of the hospital point-of-care program and the Quality Chair of the Department of Pathology. He is a Professor at Harvard Medical School with research interests in the evaluation of point-of-care technologies and outcomes studies concerning implementation of point-of-care testing. Dr. Lewandrowski was trained in anatomic and clinical pathology at the Massachusetts General Hospital and has been on the staff of the department of Pathology since 1991. He is also editor in chief of the medical journal “Point of Care: The Journal of Near Patient Testing Technologies”.

Speaking in:

    How do we Determine if Testing is Appropriate versus Inappropriate?


Penny Colbourne

Dr. Penny Colbourne is a Clinical Toxicologist working in the Toxicology Laboratory at the University of Alberta Hospital
and is a Clinical Professor at the University of Alberta in the Faculty of Medicine and Dentistry. She has a B.Sc. in Medical Laboratory Science and a Ph.D. in Pharmaceutical Sciences, both from the University of Alberta. Dr. Colbourne is a Fellow of the American Board of Forensic Toxicology, is a Board Member of the Alberta Society for Human Toxicology and is co-Chair for the Alberta Health Services’ provincial Toxicology Network. Dr. Colbourne is an inspector for the National Laboratory Certification Program, a U.S based program, and the College of American Pathologists – Forensic Drug Testing Program, inspecting forensic drug testing laboratories. Dr. Colbourne has presented at both national and international conferences and makes scientific presentations to the medical and technical community, the business sector and to government groups. She has several publications to her credit and has testified in both Family Court of Alberta and Alberta Court of Queen’s Bench as an Expert Witness.

Speaking in:

    A Successful Change Strategy Addressing Overutilization of Stat Drug Tests, with Emphasis on Collaboration between Labs and Clinical Staff

Sacha Bhatia

Dr. R. Sacha Bhatia is the Director of the Institute for Health System Solutions and Virtual Care (WIHV) at Women’s College Hospital, where he also a staff cardiologist. As Director of WIHV, Dr. Bhatia leads evaluation for Choosing Wisely Canada, a national initiative managed through the University of Toronto in collaboration with the CMA. He is also appointed as Assistant Professor at the University of Toronto and as an adjunct scientist at the Institute for Clinical Evaluative Sciences. Previously he worked as a clinical and research fellow in cardiology at Massachusetts General Hospital and Harvard University. Dr. Bhatia received his medical degree and MBA at McGill University and his internal medicine and cardiology training in Toronto.

Speaking in:

    Choosing Wisely Canada

Tara Gomes

Dr. Tara Gomes is an epidemiologist and Principal Investigator of the Ontario Drug Policy Research Network (ODPRN), a provincial network of researchers with expertise in pharmaceutical utilization, outcomes and policy who rapidly conduct research for drug decision-makers in Ontario and across Canada. She is also a Scientist in the Li Ka Shing Knowledge Institute of St. Michael’s Hospital and the Institute for Clinical Evaluative Sciences and an assistant professor at the University of Toronto. Her research is focused on pharmacoepidemiology, drug safety and drug policy research leveraging large, administrative databases, and she has published over 125 peer-reviewed articles and over 50 policy reports in this area.
Dr. Gomes has worked closely with the Ontario Ministry of Health and Long-Term Care and the Canadian Network for Observational Drug Effect Studies (CNODES) to develop evidence to inform policies related to opioid use and abuse in Ontario and more broadly across Canada. She has also served as an expert for the US Food and Drug Administration and the US Department of Transportation in discussions related to opioid policies and regulations. In 2014, the ODPRN was awarded the Institute for Public Administration of Canada’s Bronze Public Sector Leadership Award in Health and Education.

Speaking in:

    Using Data and Policy to Drive Change – Home Glucose Testing in Ontario